Compare BIO & AU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | AU |
|---|---|---|
| Founded | 1952 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Precious Metals |
| Sector | Industrials | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 47.9B |
| IPO Year | N/A | 1972 |
| Metric | BIO | AU |
|---|---|---|
| Price | $293.55 | $112.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $358.50 | $91.67 |
| AVG Volume (30 Days) | 233.7K | ★ 3.4M |
| Earning Date | 02-12-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 1.80% |
| EPS Growth | N/A | ★ 237.48 |
| EPS | N/A | ★ 4.53 |
| Revenue | $2,557,500,000.00 | ★ $8,575,000,000.00 |
| Revenue This Year | $1.50 | $72.67 |
| Revenue Next Year | $2.23 | $26.20 |
| P/E Ratio | ★ N/A | $23.99 |
| Revenue Growth | N/A | ★ 61.82 |
| 52 Week Low | $211.43 | $28.45 |
| 52 Week High | $343.12 | $115.81 |
| Indicator | BIO | AU |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 62.36 |
| Support Level | $287.59 | $96.01 |
| Resistance Level | $301.47 | $105.61 |
| Average True Range (ATR) | 9.30 | 5.58 |
| MACD | -0.33 | 0.13 |
| Stochastic Oscillator | 27.51 | 83.05 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.